secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifeward Ltd. (LFWD)
CIK:        0001607962
Form:       8-K
Filed at:   2026-07-07T20:30:21+00:00
Accession:  0001178913-26-003429
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifeward issues $5.58M initial convertible notes; additional $5.58M contingent on milestones
--------------------------------------------------------------------------------

- Initial $5.58M senior secured convertible notes at 8% interest, convertible at $5.40/share.
- Additional $5.58M notes require 150% ReWalk unit sales growth or stock price ≥$13.80 for 10 days.
- Warrants for 100% of conversion shares at $5.40 exercise price, 5-year term.
- Beneficial ownership limited to 4.99%; exchange cap at 19.99% unless shareholder approval.
- Oramed Pharmaceuticals acts as collateral agent for the transaction.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1607962/000117891326003429/0001178913-26-003429-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1607962/000117891326003429/zk2635657.htm
  HTML page:      https://secwatch.observer/filing/0001178913-26-003429

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer